Pfizer in talks to acquire Seagen for likely for more than USD 30 bilion - WSJ
US: Pfizer Inc is in early talks to acquire drugmaker Seagen Inc, the Wall Street Journal reported late on Sunday, citing people familiar with the matter.
Seagen has a market value of some $30 billion and would be expected to command a premium over that, the report said, adding that the deal talks are in preliminary stages.
Read also: USFDA grants priority review to Pfizer Elranatamab for relapsed or refractory multiple myeloma
Pfizer declined to comment on the report, while Seagen did not immediately respond to Reuters request for a comment.
Seagen was in advanced talks last year to be acquired by Merck, in a deal that would have been worth $40 billion or more, the Journal reported at the time, but the two sides failed to reach agreement.
Next Story
